IDEAS home Printed from https://ideas.repec.org/a/nat/natcom/v15y2024i1d10.1038_s41467-024-55251-5.html
   My bibliography  Save this article

Characterizing mutation-treatment effects using clinico-genomics data of 78,287 patients with 20 types of cancers

Author

Listed:
  • Ruishan Liu

    (Stanford University
    University of Southern California)

  • Shemra Rizzo

    (Genentech)

  • Lisa Wang

    (Genentech)

  • Nayan Chaudhary

    (Genentech)

  • Sophia Maund

    (Genentech)

  • Marius Rene Garmhausen

    (F. Hoffmann-La Roche Ltd.)

  • Sarah McGough

    (Genentech)

  • Ryan Copping

    (Genentech)

  • James Zou

    (Stanford University
    Stanford University)

Abstract

Evaluating the effectiveness of cancer treatments in relation to specific tumor mutations is essential for improving patient outcomes and advancing the field of precision medicine. Here we represent a comprehensive analysis of 78,287 U.S. cancer patients with detailed somatic mutation profiling integrated with treatment and outcomes data extracted from electronic health records. We systematically identified 776 genomic alterations associated with survival outcomes across 20 distinct cancer types treated with specific immunotherapies, chemotherapies, or targeted therapies. Additionally, we demonstrate how mutations in particular pathways correlate with treatment response. Leveraging the large number of identified predictive mutations, we developed a machine learning model to generate a risk score for response to immunotherapy in patients with advanced non-small cell lung cancer (aNSCLC). Through rigorous computational analysis of large-scale clinico-genomic real-world data, this research provides insights and lays the groundwork for further advancements in precision oncology.

Suggested Citation

  • Ruishan Liu & Shemra Rizzo & Lisa Wang & Nayan Chaudhary & Sophia Maund & Marius Rene Garmhausen & Sarah McGough & Ryan Copping & James Zou, 2024. "Characterizing mutation-treatment effects using clinico-genomics data of 78,287 patients with 20 types of cancers," Nature Communications, Nature, vol. 15(1), pages 1-10, December.
    • Handle: RePEc:nat:natcom:v:15:y:2024:i:1:d:10.1038_s41467-024-55251-5
    DOI: 10.1038/s41467-024-55251-5
    as

    Download full text from publisher

    File URL: https://www.nature.com/articles/s41467-024-55251-5
    File Function: Abstract
    Download Restriction: no
    File URL: https://libkey.io/10.1038/s41467-024-55251-5?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    References listed on IDEAS

    as
    1. Ruishan Liu & Shemra Rizzo & Samuel Whipple & Navdeep Pal & Arturo Lopez Pineda & Michael Lu & Brandon Arnieri & Ying Lu & William Capra & Ryan Copping & James Zou, 2021. "Evaluating eligibility criteria of oncology trials using real-world data and AI," Nature, Nature, vol. 592(7855), pages 629-633, April.
    Full references (including those not matched with items on IDEAS)

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Chengxi Zang & Hao Zhang & Jie Xu & Hansi Zhang & Sajjad Fouladvand & Shreyas Havaldar & Feixiong Cheng & Kun Chen & Yong Chen & Benjamin S. Glicksberg & Jin Chen & Jiang Bian & Fei Wang, 2023. "High-throughput target trial emulation for Alzheimer’s disease drug repurposing with real-world data," Nature Communications, Nature, vol. 14(1), pages 1-16, December.

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:15:y:2024:i:1:d:10.1038_s41467-024-55251-5. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.